DKK1 and endometrial cancer: A new in vivo study conducted in mice showed that E-MSCs but not AT- or UC-MSCs, could suppress malignant endometrial cancer through inhibition of the Wnt/β-catenin signaling pathway by secreting high levels of Dickkopf-related protein 1 (DKK1) [87].